Orito E - Search Results

1

Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy.

Orito E, Mizokami M, Mizoguchi N, Ohba K, Tohnai M, Yamanaka H, Oguri T, Hirashima N, Koide T, Kano H, et al. Orito E, et al. J Hepatol. 1994 Jul;21(1):130-2. doi: 10.1016/s0168-8278(94)80149-5. J Hepatol. 1994. PMID: 7525694 Clinical Trial.

2

Therapy of chronic hepatitis due to HCV.

Orito E, Mizokami M. Orito E, et al. Trop Gastroenterol. 1994 Oct-Dec;15(4):186-90. Trop Gastroenterol. 1994. PMID: 7542410 Review. No abstract available.

3

Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.

Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY. Orito E, et al. J Med Virol. 1995 Jun;46(2):109-15. doi: 10.1002/jmv.1890460205. J Med Virol. 1995. PMID: 7636496

4

Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus.

Ohno T, Mizokami M, Yamauchi M, Ohba K, Orito E, Wu RR, Mizuno M, Sugihara K, Wakita T, Kakumu S. Ohno T, et al. Among authors: orito e. J Gastroenterol. 1995 Apr;30(2):209-14. doi: 10.1007/BF02348667. J Gastroenterol. 1995. PMID: 7773352

5

[Relation between HCV genotype and serum HCV RNA level as predictors of response to interferon-alfa 2b therapy in chronic hepatitis C].

Orito E, Mizokami M. Orito E, et al. Nihon Rinsho. 1994 Jul;52(7):1754-8. Nihon Rinsho. 1994. PMID: 8078199 Japanese.

6

Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes.

Mizokami M, Gojobori T, Ohba K, Ikeo K, Ge XM, Ohno T, Orito E, Lau JY. Mizokami M, et al. Among authors: orito e. J Hepatol. 1996 May;24(5):622-4. doi: 10.1016/s0168-8278(96)80149-8. J Hepatol. 1996. PMID: 8773919

7

Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C.

Mizoguchi N, Mizokami M, Orito E, Shibata H, Shibata H. Mizoguchi N, et al. Among authors: orito e. J Virol Methods. 1996 Apr 26;58(1-2):71-9. doi: 10.1016/0166-0934(95)01989-8. J Virol Methods. 1996. PMID: 8783152

8

Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.

Mizokami M, Orito E, Gibo Y, Suzuki K, Ohba K, Ohno T, Lau JY. Mizokami M, et al. Among authors: orito e. Liver. 1996 Feb;16(1):23-7. doi: 10.1111/j.1600-0676.1996.tb00699.x. Liver. 1996. PMID: 8868074

9

Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.

Hirashima N, Mizokami M, Orito E, Koide T, Itazu I, Kumada K, Sakakibara K, Kano H, Lau JY. Hirashima N, et al. Among authors: orito e. J Gastroenterol Hepatol. 1996 Oct;11(10):955-8. J Gastroenterol Hepatol. 1996. PMID: 8912134

10

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.

Orito E, Mizokami M, Suzuki K, Ohba KI, Ohno T, Mizuno M, Iijima Y, Saito H, Nemoto A, Nukuta N. Orito E, et al. J Gastroenterol Hepatol. 1997 Jan;12(1):58-61. doi: 10.1111/j.1440-1746.1997.tb00347.x. J Gastroenterol Hepatol. 1997. PMID: 9076625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters